Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells.
Pinz KG, Yakaboski E, Jares A, Liu H, Firor AE, Chen KH, Wada M, Salman H, Tse W, Hagag N, Lan F, Leung EL, Jiang X, Ma Y.
Pinz KG, et al. Among authors: jares a.
Oncotarget. 2017 Nov 22;8(68):112783-112796. doi: 10.18632/oncotarget.22626. eCollection 2017 Dec 22.
Oncotarget. 2017.
PMID: 29348865
Free PMC article.